Search research articles
Contact Us
Filters
Showing results (381-390 of 475) with videos related to
Page
of 48
Sort By:
Seminars in Oncology
|
August 1, 1995
A phase I study of ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer
G M Strauss, T J Lynch, A D Elias, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 1, 1997
Neoadjuvant therapy for surgically staged IIIA N2 non-small cell lung cancer (NSCLC)
A D Elias, A T Skarin, T Leong, et al.
Cardiology in the Young
|
May 3, 2017
Exercise restriction is not associated with increasing body mass index over time in patients with anomalous aortic origin of the coronary arteries
James M Meza, Matthew D Elias, Travis J Wilder, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 8, 2011
Importance of gender in diffuse malignant peritoneal mesothelioma
C Cao, T D Yan, M Deraco, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 6, 1996
A role of Hsp60 in autoimmune diabetes: analysis in a transgenic model
O S Birk, D C Douek, D Elias, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 14, 2004
The doxorubicin-streptozotocin combination for the treatment of advanced well-differentiated pancreatic endocrine carcinoma; a judicious option?
Th Delaunoit, M Ducreux, V Boige, et al.
Seminars in Oncology
|
August 1, 1997
Ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer: update and preliminary survival analysis
G M Strauss, T J Lynch, A D Elias, et al.
Oncology
|
April 29, 2006
A phase II study of irinotecan with 5-fluorouracil and leucovorin in patients with pretreated gastroenteropancreatic well-differentiated endocrine carcinomas
M P Ducreux, V Boige, S Leboulleux, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 19, 2006
Phase II trial of bevacizumab in combination with weekly docetaxel in metastatic breast cancer patients
Bhuvaneswari Ramaswamy, Anthony D Elias, Nicole T Kelbick, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 21, 2010
The angiotensin IV analog Nle-Tyr-Leu-psi-(CH2-NH2)3-4-His-Pro-Phe (norleual) can act as a hepatocyte growth factor/c-Met inhibitor
B J Yamamoto, P D Elias, J A Masino, et al.
Page
of 48
Search research articles
Search
Showing results (381-390 of 475) with videos related to
Sort By:
Page
of 48
Seminars in Oncology
|
August 1, 1995
A phase I study of ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer
G M Strauss, T J Lynch, A D Elias, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 1, 1997
Neoadjuvant therapy for surgically staged IIIA N2 non-small cell lung cancer (NSCLC)
A D Elias, A T Skarin, T Leong, et al.
Cardiology in the Young
|
May 3, 2017
Exercise restriction is not associated with increasing body mass index over time in patients with anomalous aortic origin of the coronary arteries
James M Meza, Matthew D Elias, Travis J Wilder, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 8, 2011
Importance of gender in diffuse malignant peritoneal mesothelioma
C Cao, T D Yan, M Deraco, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 6, 1996
A role of Hsp60 in autoimmune diabetes: analysis in a transgenic model
O S Birk, D C Douek, D Elias, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 14, 2004
The doxorubicin-streptozotocin combination for the treatment of advanced well-differentiated pancreatic endocrine carcinoma; a judicious option?
Th Delaunoit, M Ducreux, V Boige, et al.
Seminars in Oncology
|
August 1, 1997
Ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer: update and preliminary survival analysis
G M Strauss, T J Lynch, A D Elias, et al.
Oncology
|
April 29, 2006
A phase II study of irinotecan with 5-fluorouracil and leucovorin in patients with pretreated gastroenteropancreatic well-differentiated endocrine carcinomas
M P Ducreux, V Boige, S Leboulleux, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 19, 2006
Phase II trial of bevacizumab in combination with weekly docetaxel in metastatic breast cancer patients
Bhuvaneswari Ramaswamy, Anthony D Elias, Nicole T Kelbick, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 21, 2010
The angiotensin IV analog Nle-Tyr-Leu-psi-(CH2-NH2)3-4-His-Pro-Phe (norleual) can act as a hepatocyte growth factor/c-Met inhibitor
B J Yamamoto, P D Elias, J A Masino, et al.
Page
of 48